PureTech Reveals New CBD Pill to Rival Jazz’s Epidiolex 4K [iDyqOY5uPQ8]

PureTech Reveals New CBD Pill to Rival Jazz’s Epidiolex 4K [iDyqOY5uPQ8]

| 1h 28m 28s | Video has closed captioning.

Clinical-stage biotech company PureTech recently announced development of an oral capsule CBD candidate therapeutic for the treatment of seizures associated with rare forms of epilepsy. Currently, Jazz Pharma’s Epidiolex is the only approved CBD product for medical use. Unlike Epidiolex, which is an oral solution of CBD, PureTech’s CBD capsule does not include sesame oil in its formulation, which would expand its use to people with a sesame allergy. PureTech says its CBD capsule also demonstrates improved bioavailability, tolerability, and reduced GI side effects. Hear more in this video and click on the article below for the full story. Read more on this story here: PureTech Reveals New CBD Pill to Rival Jazz’s Epidiolex - Receive weekly news and webinar updates right in your inbox: Listen live and interact with featured speakers on our upcoming Life Science webinars: #shorts #cbd #Cannabidiol #epilepsy